• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>NewAlliance Bancshares

NewAlliance Bancshares

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. MM-398 Receiving the Priority Review Designation by US FDA for New Drug Application and the Acceptance of Market Authorization Application by EMA in Post-Gemcitabine Metastatic Pancreatic Cancer

    MM-398 Receiving the Priority Review Designation by US FDA for New Drug Application and the Acceptance of Market Authorization Application by EMA in Post-Gemcitabine Metastatic Pancreatic Cancer

  2. Research and Markets: Herpes Zoster (Shingles) Pipeline Review, H1 2015 - 7 Companies & 9 Drug Profiles

    Research and Markets: Herpes Zoster (Shingles) Pipeline Review, H1 2015 - 7 Companies & 9 Drug Profiles

  3. Research and Markets: Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2015

    Research and Markets: Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2015

  4. Lifting the Curtain on Changes at American Funds Bond Fund of America

    Recent changes to this fund's portfolio manager structure shows much tinkering going on.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.